These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 24161443)

  • 21. Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating CKIP-1 to resist HG-induced up-regulation of FN and ICAM-1 in GMCs and diabetic mice kidneys.
    Gong W; Li J; Chen Z; Huang J; Chen Q; Cai W; Liu P; Huang H
    Free Radic Biol Med; 2017 May; 106():393-405. PubMed ID: 28286065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells.
    Huang K; Huang J; Xie X; Wang S; Chen C; Shen X; Liu P; Huang H
    Free Radic Biol Med; 2013 Dec; 65():528-540. PubMed ID: 23891678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of Nrf2 Signaling Normalizes the Regenerative Niche.
    Soares MA; Cohen OD; Low YC; Sartor RA; Ellison T; Anil U; Anzai L; Chang JB; Saadeh PB; Rabbani PS; Ceradini DJ
    Diabetes; 2016 Mar; 65(3):633-46. PubMed ID: 26647385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
    Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
    Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
    Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
    J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
    Xu J; Xiang P; Liu L; Sun J; Ye S
    J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connexin43 regulates high glucose-induced expression of fibronectin, ICAM-1 and TGF-β1 via Nrf2/ARE pathway in glomerular mesangial cells.
    Chen Z; Xie X; Huang J; Gong W; Zhu X; Chen Q; Huang J; Huang H
    Free Radic Biol Med; 2017 Jan; 102():77-86. PubMed ID: 27840317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
    Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
    Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
    Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
    J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel compound AB38b attenuates oxidative stress and ECM protein accumulation in kidneys of diabetic mice through modulation of Keap1/Nrf2 signaling.
    Du L; Wang L; Wang B; Wang J; Hao M; Chen YB; Li XZ; Li Y; Jiang YF; Li CC; Yang H; Gu XK; Yin XX; Lu Q
    Acta Pharmacol Sin; 2020 Mar; 41(3):358-372. PubMed ID: 31645661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Hu X; Li D; Zhan J; Yang C; Wang P; Meng X; Xu S; Che X; Xu L
    DNA Cell Biol; 2024 May; 43(5):245-257. PubMed ID: 38489601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
    Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
    J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CircRNA SCMH1 regulates the miR-200a-3p/ZEB1 signaling axis to promote diabetes-induced retinal epithelial-mesenchymal transition.
    He Y; Hou XT; Guan YX; Chen Y
    Exp Eye Res; 2022 Nov; 224():109264. PubMed ID: 36162459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-200a-3p-enriched MSC-derived extracellular vesicles reverse erectile function in diabetic rats by targeting Keap1.
    Zhang J; Zhao D; Zang Z; Ruan Z; Fu Q; Zhang K
    Biomed Pharmacother; 2024 Aug; 177():116964. PubMed ID: 38959607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a/Keap1/Nrf2 pathway, renin-angiotensin system (RAS) and NF-кB.
    Noei Razliqi R; Ahangarpour A; Mard SA; Khorsandi L
    Chem Biol Interact; 2023 Aug; 380():110507. PubMed ID: 37120126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
    Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nop-7-associated 2 (NSA2), a candidate gene for diabetic nephropathy, is involved in the TGFβ1 pathway.
    Shahni R; Czajka A; Mankoo BS; Guvenel AK; King AJ; Malik AN
    Int J Biochem Cell Biol; 2013 Mar; 45(3):626-35. PubMed ID: 23220173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.